Ingrid Goldberg | VP of IR |
William Doyle | Executive Chairman |
Asaf Danziger | CEO |
Ashley Cordova | CFO |
Pritesh Shah | Chief Growth Officer |
Jason Bednar | Piper Sandler |
Emily Bodnar | H.C. Wainwright |
Good day, and thank you for standing by. Welcome to the NovoCure Q2 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers' presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that today's conference is being recorded.